Veru

+$0.31 (+4.28%) Today
-$0.19 (-2.51%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Veru and other stocks, options, and ETFs commission-free!

About VERU

Veru Inc. Common Stock, also called Veru, is an oncology biopharmaceutical company engaged in developing novel medicines for the management of prostate cancer and breast cancer.

CEO
Mitchell Shuster Steiner
Employees
339
Headquarters
Miami, Florida
Founded
1996

VERU Key Statistics

Market Cap
612.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.09M
High Today
$7.72
Low Today
$7.28
Open Price
$7.32
Volume
943.93K
52 Week High
$24.57
52 Week Low
$2.30

VERU News

BenzingaMay 12

Veru: Q2 Earnings Insights

Shares of Veru (NASDAQ:VERU) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share fell 300.00% over the past year t

VERU Earnings

-$0.06
-$0.03
$0.00
$0.03
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.04 per share
Actual
-$0.04 per share
Replay Earnings Call

You May Also Like

AQNA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure